Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Selection and characterization of anti-MUC-1 scFvs intended for targeted therapy.

Winthrop MD, DeNardo SJ, Albrecht H, Mirick GR, Kroger LA, Lamborn KR, Venclovas C, Colvin ME, Burke PA, DeNardo GL.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3845S-53S.

2.

Apoptosis-related gene and protein expression in human lymphoma xenografts (Raji) after low dose rate radiation using 67Cu-2IT-BAT-Lym-1 radioimmunotherapy.

Kroger LA, DeNardo GL, Gumerlock PH, Xiong CY, Winthrop MD, Shi XB, Mack PC, Leshchinsky T, DeNardo SJ.

Cancer Biother Radiopharm. 2001 Jun;16(3):213-25.

PMID:
11471486
3.

Antibody phage display applications for nuclear medicine imaging and therapy.

Winthrop MD, Denardo GL, Denardo SJ.

Q J Nucl Med. 2000 Sep;44(3):284-95.

PMID:
11105591
4.

Apoptotic and proliferation indexes in canine lymphoma.

Phillips BS, Kass PH, Naydan DK, Winthrop MD, Griffey SM, Madewell BR.

J Vet Diagn Invest. 2000 Mar;12(2):111-7.

PMID:
10730938
5.

Development of a hyperimmune anti-MUC-1 single chain antibody fragments phage display library for targeting breast cancer.

Winthrop MD, DeNardo SJ, DeNardo GL.

Clin Cancer Res. 1999 Oct;5(10 Suppl):3088s-3094s.

PMID:
10541348
6.

Effect of 67Cu-2IT-BAT-Lym-1 therapy on BCL-2 gene and protein expression in a lymphoma mouse model.

Kroger LA, DeNardo SJ, DeNardo GL, Xiong CY, Winthrop MD, Gumerlock PH.

Clin Cancer Res. 1999 Oct;5(10 Suppl):3010s-3014s.

PMID:
10541336
7.

Antibody phage libraries for the next generation of tumor targeting radioimmunotherapeutics.

DeNardo SJ, DeNardo GL, DeNardo DG, Xiong CY, Shi XB, Winthrop MD, Kroger LA, Carter P.

Clin Cancer Res. 1999 Oct;5(10 Suppl):3213s-3218s.

PMID:
10541366
8.

Yttrium-90-DOTA-peptide-chimeric L6 radioimmunoconjugate: efficacy and toxicity in mice bearing p53 mutant human breast cancer xenografts.

DeNardo SJ, Kukis DL, Miers LA, Winthrop MD, Kroger LA, Salako Q, Shen S, Lamborn KR, Gumerlock PH, Meares CF, DeNardo GL.

J Nucl Med. 1998 May;39(5):842-9.

9.

p53-independent response of a human breast carcinoma xenograft to radioimmunotherapy.

Winthrop MD, DeNardo SJ, Muenzer JT, Chi SG, Gumerlock PH.

Cancer. 1997 Dec 15;80(12 Suppl):2529-37.

PMID:
9406706
10.

Decreased C-MYC and BCL2 expression correlates with methylprednisolone-mediated inhibition of Raji lymphoma growth.

Morris G, DeNardo SJ, DeNardo GL, Leshchinsky T, Wu B, Mack PC, Winthrop MD, Gumerlock PH.

Biochem Mol Med. 1997 Apr;60(2):108-15.

PMID:
9169090
11.

Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression.

DeNardo SJ, Gumerlock PH, Winthrop MD, Mack PC, Chi SG, Lamborn KR, Shen S, Miers LA, deVere White RW, DeNardo GL.

Cancer Res. 1995 Dec 1;55(23 Suppl):5837s-5841s.

Supplemental Content

Loading ...
Support Center